The global high performance medical plastics market size is projected to grow from USD 851 million in 2021 to USD 1,242 million by 2026, at a CAGR of 7.8% during the forecast period 2021 to 2026. The growing use of advanced medical technologies, such as 3D printed implants and customized devices is one of the major factor propelling the growth of the high performance medical plastics market.
North America accounted for the largest share of the high performance medical plastics market in 2020. The countries countries considered for the study in North America are the US, Canada, and Mexico. High performance medical plastics are used in the manufacturing of medical devices and equipment employed in the healthcare industry for surgical and procedural applications. The medical devices market in North America is highly diversified and offers a variety of products to diagnose and treat patients, ranging from medical catheters to vascular grafts and implants. Companies in North America mainly focus on the development of high-quality products using advanced technology, which mandates significant investment in R&D. New innovations, such as neuro-stimulators, stent technologies, biomarkers, robotic assistance, and implantable electronic devices in the medical device market in North America, are leading to the overall growth of the healthcare industry. The demand for high performance medical plastics is expected to increase rapidly in this region in certain application areas, such as orthopedics, medical instruments, and implants.
To know about the assumptions considered for the study download the pdf brochure
Solvay SA (Belgium), SABIC (UAE), Mitsubishi Chemical Corporation (Japan), Evonik Industries AG (Germany), Arkema SA (France), Ensinger (Germany), Victrex PLC (UK), Rochling SE & Co. AG (Germany), Raumedic AG (Germany), The Chemours Company (US), DuPont (US), Saint-Gobain Performance Plastics (France), Celanese Corporation (US), Trelleborg (Sweden) and Tekni-Plex (US) are some of the leading players operating in the high performance medical plastics market. These players have adopted the strategies of acquisitions and partnerships to enhance their position in the market.
Solvay SA is the largest company in the global high performance medical plastics market. High performance plastics are a part of the materials business segment of the company. Solvay SA operates through 428 subsidiaries in 64 countries of Europe, North America, Latin America, and Asia-Pacific. The company has 119 operational facilities worldwide. As a global leader in materials, chemicals, and solutions, Solvay brings advancements in planes, cars, batteries, smart and medical devices, and water and air treatment, to solve critical industrial, social, and environmental challenges. Solvay SA, in December 2020 entered into a partnership with PrinterPrezz (US) to develop 3D printing Selective Laser Sintering (SLS) solutions for implants and other medical devices using high performance polymers.
Another important player in the high performance medical plastics market is Evonik Industries AG. The company has vast experience in manufacturing high performance medical plastics and a broad product portfolio, huge production capacity, and sales, logistics, and technical service network. Evonik has a dedicated section for medical plastic division and products like VESTAKEEP, VESTAMID and TRAGOMID care have application in dental applications, body implants and medical devices. Evonik is one of the world leaders in specialty chemicals. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. The company has done major acquisitions and joint ventures with companies like Durect Corporation and Wynka Silicon for increasing its high performance medical plastics market.
Request for Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=146073142
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, and strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Media ContactCompany Name: MarketsandMarketsContact Person: Mr. Aashish MehraEmail: Send EmailPhone: 18886006441Address:630 Dundee Road Suite 430City: NorthbrookState: IL 60062Country: United StatesWebsite: https://www.marketsandmarkets.com/Market-Reports/high-performance-medical-plastics-market-146073142.html
